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Mammary stroma is essential for epithelial morphogenesis and development. Indeed, post-
natal mammary gland (MG) development is controlled locally by the repetitive and bi-
directional cross-talk between the epithelial and the stromal compartment. However, the
signalling pathways involved in stromal–epithelial communication are not entirely under-
stood. Here, we identify Sfrp3 as a mediator of the stromal–epithelial communication that is
required for normal mouse MG development. Using Drosophila wing imaginal disc, we
demonstrate that Sfrp3 functions as an extracellular transporter of Wnts that facilitates their
diffusion, and thus, their levels in the boundaries of different compartments. Indeed, loss of
Sfrp3 in mice leads to an increase of ductal invasion and branching mirroring an early
pregnancy state. Finally, we observe that loss of Sfrp3 predisposes for invasive breast cancer.
Altogether, our study shows that Sfrp3 controls MG morphogenesis by modulating the
stromal-epithelial cross-talk during pubertal development.
https://doi.org/10.1038/s41467-019-10509-1 OPEN
1 Department of Development and Regeneration, Centro de Biologia Molecular Severo Ochoa (CSIC-UAM), 28049 Madrid, Spain. 2 Department of Molecular
Biomedicine, Centro de Investigaciones Biologicas (CSIC), 28040 Madrid, Spain. 3 Centre for Integrative Physiology, University of Edinburgh, Edinburgh EH8
9XB, UK. Correspondence and requests for materials should be addressed to F.M.-B. (email: fmartin@cbm.csic.es)









The mammary gland (MG) is one of the few organs thatundergoes most of its development postnatally. At puberty,the ducts of the rudimentary embryonic tree start to invade
the mammary fat pad through a process of ductal elongation and
bifurcation, driven by the terminal end buds (TEBs) structures
located at the tips of the ducts, and through a process of sec-
ondary side branching. Once the ducts reach the edges of the
mammary fat pad, the TEBs regress and the arborized ductal tree
remains quiescent until pregnancy, except for the formation of
tertiary side branches at each oestrus cycle1. During pregnancy a
massive process of tertiary side branching results into lobu-
loalveolar structures that ultimately differentiate into alveoli,
producing and secreting milk during lactation2. At weaning, the
MG reverts to the adult virgin-like MG state. During each phase
of MG development profound changes in cell proliferation,
apoptosis and differentiation occur, allowing a constant remo-
delling of the gland structure.
The MG is composed of two compartments, the epithelial
ducts and the stroma in which ducts are embedded. Postnatal MG
development is controlled globally by systemic hormones and
locally by the repetitive and bi-directional cross-talk between the
epithelial and the stromal compartment3. Many studies have
shown that mammary stroma instructs differentiation and
branching of mammary epithelial cells through paracrine signals,
and sustains cell fate maintenance during postnatal life4. The
paracrine signalling between epithelial and stromal cells is based
on secreted factors like the Wnt ligands5,6.
The Wnt signalling pathway control multiple steps of MG
development and dysregulation of Wnt signalling has been
associated with breast cancer (BC)7. While mutations in the core
genes of the canonical Wnt signalling pathway, namely βcatenin,
APC, or axin2, are rare, loss by epigenetic silencing of Wnt
inhibitors like secreted frizzled-related protein (Sfrp) family
members is more frequent, and it has been associated with
human BC8.
The Sfrps are a family of secreted glycoproteins composed of
five members in mammals, containing an N-terminal domain
homologous to the cysteine-rich domain (CRD) of the Frizzled
Receptor and a C-terminal domain with some homology to the
netrin domain (NTR)9. Sfrp3 (also known as FRZB) is considered
as the founding member of the Sfrp family10, and identified as an
inhibitor of Wnt signalling11,12. Sfrp3 has an essential role in
bone development and cartilage homoeostasis, dependent and
independent of Wnt signalling13–15. Remarkably, we identify
Sfrp3 as a potential regulator of 3D-epithelial polarity16. Indeed,
Sfrp3 levels are downregulated in different human epithelial
cancers, underscoring its importance for normal epithelial
architecture17. Recent reports demonstrated that human BC lack
expression of Sfrp316, and also a positive association between
polymorphisms of Sfrp3 and predisposition to BC18. However,
whether Sfrp3 has a fundamental role in MG morphogenesis and
cancer onset was previously unknown.
In the present study, we show that loss of Sfrp3 results in
increased ductal elongation and tertiary branching during pub-
ertal MG development. This advanced lobuloalveolar develop-
ment is accompanied by structural defects of epithelial ducts.
Sfrp3 knockout luminal epithelial cells show increased prolifera-
tion, with loss of polarity features, and they are abnormally dif-
ferentiated into milk-secreting cells. Transplantation experiments
and 3D cultures reveal that the ductal phenotype results from the
loss of stromal Sfrp3. Also, we demonstrate that SFRP3 functions
as an extracellular transporter of Wnts using the larval model of
Drosophila, and show that SFRP3 control the levels of Wnts that
accumulate in the stromal–epithelial boundary, thus modulating
the proliferative and branching response of the epithelium during
MG morphogenesis. Finally, we identify that lack of Sfrp3 in
MMTV-Neu animals induces the precocious appearance of pre-
malignant lesions, suggesting a role for Sfrp3 as a marker for BC
susceptibility. Collectively, our results show that stromal Sfrp3
regulates the Wnt-mediated epithelial–stromal interactions in the
MG development.
Results
Stromal and epithelial cells of the MG express Sfrp3. In order to
investigate the role of Sfrp3 in MG morphogenesis, we examined
the expression of Sfrp3 during MG development. Sfrp3 mRNA
expression is high at the pre-pubertal stage (3 weeks old) and
decreases throughout puberty (6–8 weeks old). During preg-
nancy, its expression is further reduced (Fig. 1a). We also
examined the expression of all Sfrp family members during MG
development. Similarly, Sfrp2, 4 and five mRNA expression are
high at the pre-pubertal stage and decreases throughout puberty,
whereas, the levels of sfrp1 increases (Supplementary Fig. 1a). To
determine which cellular compartment within the MG expresses
Sfrp3, we separated stromal and epithelial cells from adult MGs
(12 weeks old), based on their expression of CD49f and EpCAM
cell surface markers19 (Supplementary Fig. 1b). Sfrp3 is highly
expressed in stromal cells compared to relatively low levels pre-
sent in the epithelial compartment, which includes basal/myoe-
pithelial and luminal cells (Fig. 1c). Furthermore, we detected
Sfrp3 mRNA in the mammary cleared fat pad, showing a decline
during puberty (Fig. 1b). To better dissect the source of Sfrp3,
we isolated the most abundant cell populations of the stroma,
and we identified that Sfrp3 is mostly expressed by fibroblasts
(Supplementary Fig. 1c).
In summary, we found that Sfrp3 is highly expressed at pre-
puberty before mammary ducts morphogenesis occurs, and it is
more abundant in the stromal compartment. The developmen-
tally regulated pattern of expression of Sfrp3 suggests a potential
role of Sfrp3 on MG development.
Sfrp3 prevents early ductal invasion and side branching. To
address the function of Sfrp3 during MG development, we used
the Sfrp3 knockout mouse14. Homozygous (Sfrp3−/−) mice are
viable with no apparent morphological postnatal phenotype14.
We confirmed that Sfrp3 expression is absent in Sfrp3−/− mice in
MGs (Supplementary Fig. 1d, e). To detect defects in MG mor-
phology, we examined wild-type and Sfrp3−/− virgin females with
matching oestrous cycles at different developmental stages. Both
wild-type and Sfrp3−/− mice present a regular mammary epi-
thelial tree in pre-puberty (Supplementary Fig. 1f). Differences
start to be evident at mid-puberty, when epithelial ducts are
markedly longer in Sfrp3−/− MGs, almost reaching the edges of
the fat pad (Fig. 1d, e). At the end of puberty, Sfrp3−/− ducts not
only show an accelerated invasion into the fat pad, but also a
four-fold increase increased side branching (Fig. 1d, e). Sfrp3−/−
branches terminate with small protrusions, lobuloalveolar buds,
which are typical of pregnancy (Fig. 1f). This precocious hyper-
branched phenotype persists in adult Sfrp3−/− (Fig. 1d, e). These
results suggest that Sfrp3 controls MG development by preventing
unwarranted mammary epithelial invasion and branching during
puberty.
Sfrp3 prevents ducts defects and altered differentiation. To
determine whether structural defects in Sfrp3−/− epithelial ducts,
we histologically analysed MG. Sfrp3−/− MG sections confirmed
the hyperbranched phenotype and further revealed a lumen filling
phenotype of the ducts (Fig. 2a). Whereas control ductal struc-
tures are characterised by a normal hollowed lumen, in Sfrp3−/−
MGs the lumen of 30% ducts is partially or entirely occluded
(Fig. 2a, b). Sfrp3−/− ducts display remarkable alterations in the
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structure of the luminal compartment, while the basal compart-
ment is normal (Fig. 2c). The inner luminal epithelium of
Sfrp3−/− ducts is abnormally organised into multiple layers, fill-
ing in the luminal space of ducts and branches, compared to the
single inner layer of luminal cells of the controls (Fig. 2c, d). Next,
we analysed the distribution of polarity markers. In wild-type
ducts, E-cadherin and ZO1 are localised at adherens and tight
junctions, respectively, of luminal cells (Fig. 2e). In Sfrp3−/−
ducts only the most apically localised luminal cells express
E-cadherin and ZO1, which have both a normal distribution,
comparable to controls. The expression of ZO1 is absent in
the most internal cells, whereas E-cadherin distributes uniformly
and widely along the entire cell membrane of Sfrp3−/− ducts
(Fig. 2e).
Next, we determined whether the multistratified arrangement
of Sfrp3−/− luminal cells is due to either an increase in
proliferation rate or a decrease in apoptosis rate. In control MG
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detected (Fig. 3a, b), which is consistent with the entering of post-
pubertal virgin females into a quiescent stage until pregnancy.
There is a dramatic increase in the level of proliferation in
Sfrp3−/− mature luminal cells, whereas the number of apoptotic
cells is similar to control MGs (Fig. 3a–c). Accordingly, gene
expression profiling of mammary epithelial cells from adult
Sfrp3−/− mice showed an mRNA increase of classical cell cycle
markers such as Ccnd2, Klf5, Fhl2, Id4 (Supplementary Data 1).
Luminal cells are also classified by their expression of hormone
receptors, particularly oestrogen receptor (ER). While ducts
contain both ER− and ER+ luminal cells, alveolar luminal cells
are mainly ER−20,21. We identified a substantial decrease in the
ER+ population in the Sfrp3−/− MGs (Fig. 3d, e), that suggest a
precocious alveolar development of Sfrp3−/− MGs.
The phenotype of Sfrp3−/− MGs resembles the state of early
pregnancy in wild-type mice (P8.5) when epithelial cells undergo
a process of proliferation and differentiation to form acini-like
structures that ultimately mature into alveoli—the milk secretory
structures—during pregnancy and lactation. This similarity,
together with the critical increase in the number of ER− cells,
suggested an altered differentiation of Sfrp3−/− MGs. Remark-
ably, MGs of adult virgin Sfrp3−/− virgin females expressed high
levels of ß casein compared to controls (Fig. 3f, g). ß casein was
detected inside the lumen and within luminal cells with a
subapical localisation in Sfrp3−/− mammary ducts (Fig. 3f).
Consistently, we detected higher levels of other two milk proteins,
whey acidic protein (WAP) and alpha-lactalbumin (Lalba), in
virgin Sfrp3−/− glands (Fig. 3g). Further, the expression of the
lactating alveolar marker sodium–inorganic phosphate (NaPi)-
type IIb is substantially increased (Fig. 3h). This premature
differentiation does not impair the capability of Sfrp3−/− MGs to
undergo the normal morphological changes associated with
pregnancy (Supplementary Fig. 2a, b), suggesting that alveoli are
functional and milk can flow through ducts, despite the occlusion
of the luminal space in Sfrp3−/− MGs.
We further investigated whether Sfrp3−/− showed alterations in
the stromal compartment. While we found some differences in the
extracellular matrix organisation between wild-type and Sfrp3−/−
MGs, they were not statistically relevant (Supplementary Fig. 2c–f).
Together, these observations suggest that loss of Sfrp3 leads
to a disruption of the mammary ductal structures in
virgin females, with overproliferating, and weakly polarised ER−
luminal epithelial cells that arrange in multiple layers facing the
ductal lumen and that are abnormally differentiated to a
pregnancy state.
Sfrp3 is expressed by the stroma to control MG development.
Since both stromal and epithelial cell compartments expressed
Sfrp3 mRNA (Fig. 1c), we wondered whether the branching
phenotype of Sfrp3−/− mice is due to loss of Sfrp3 either in the
stroma or in the epithelium. To address this issue, we performed
mammary epithelial transplantation experiments, consisting in
the transplantation of mammary epithelial tissue from a donor
adult mouse into the cleared fat pad of a recipient prepubertal
mouse. Five weeks after transplantation we analysed the trans-
planted and the contralateral MGs (Supplementary Fig. 3a, b).
As expected, wild-type mammary tissue, when transplanted
into wild-type cleared fat pad, grew and developed into an
epithelial tree showing a regular branching pattern, while
Sfrp3−/− transplanted epithelial cells into an Sfrp3−/− cleared
fat pad formed hyperbranched epithelial ducts (Supplementary
Fig. 3c). When Sfrp3−/− mammary epithelial cells were
transplanted into wild-type fat pad, they grew and invaded the
stroma, giving rise to a regular epithelial ductal tree similar to that
observed in the contralateral MG (Fig. 4a, b). We obtained similar
results with immunocompromised females as transplant recipi-
ents (Supplementary Fig. 3b, d). In contrast, wild-type tissue
transplanted into Sfrp3−/− stroma generated almost four-fold
increase hyperbranched epithelial network, comparable to that
observed in the Sfrp3−/− MGs (Fig. 4a–c). We obtained a similar
phenotype when wild-type tissue was transplanted into Sfrp3−/−
cleared fat pad, and allocated in immunocompromised females,
which discards a systemic effect of Sfrp3 (Supplementary Fig. 3f).
These results suggest that loss of Sfrp3 in the stroma is likely the
cause of Sfrp3−/− phenotype in MGs. Indeed, wild-type out-
growths transplanted in Sfrp3−/− stroma show a phenotype
similar to Sfrp3−/− MGs, with multilayering of luminal epithelial
cells, polarity defects, and precocious alveolar differentiation
(Fig. 4d, e), which suggests that loss of stromal Sfrp3 leads to loss
of ductal architecture. In contrast, Sfrp3−/− outgrowths trans-
planted in wild-type fat pad form a network of ducts with a
proper architecture (Fig. 4d, e, Supplementary Fig. 3e)
Consistently with the transplantation results, we did not detect
any substantial difference between wild-type and Sfrp3−/−
mammary epithelial organoids in terms of either organoid
structure/size or lumen volume. Also, in the absence of growth
factors neither wild-type nor Sfrp3−/− organoids form branches
(Supplementary Fig. 4a). Neither, we did observe any substantial
difference in the frequency of wild-type and Sfrp3−/− epithelial
cells able to generate mammospheres, which is used to estimate
the number of mammary stem cells (MaSC) in the epithelial
tissue22 (Supplementary Fig. 4a). Together, these results indicate
that the abnormal features of the ductal phenotype in Sfrp3−/−
MG arise from loss of Sfrp3 in the stroma, rather than in the
epithelium.
Sfrp3 functions in a hormonally stimulated environment.
Ovarian oestrogen and progesterone are the central systemic
regulators of MG development during puberty and pregnancy.
Higher levels of progesterone23 accompany the formation of
alveolar-like structures during the diestrus phase of the oestrous
cycle and pregnancy23. In the absence of ovarian hormones,
Sfrp3−/− ducts do not elongate and do not show any alteration in
branching rate or structural organisation (Supplementary
Fig. 4b). Additionally, we detected no increase in the serum levels
of oestrogen and progesterone in Sfrp3−/− females
Fig. 1 Epithelial invasion and tertiary-side branching increase in Sfrp3−/− MG. a Relative Sfrp3mRNA level in whole MG at 3, 6, 8 weeks (weeks) of age and
at pregnancy (P) day 8.5 and 13.5. n= 4 females/age, except for P8.5, n= 3 females. b Relative Sfrp3mRNA level in cleared mammary fat pad of females at
3 and 8 weeks of age. n= 4 females/age. c Relative Sfrp3 mRNA level in FACS-sorted mammary epithelial and stromal cells. n= 2 pools, each pool
collected from 15 females at 12 weeks of age. d Representative whole mount of MGs from Sfrp3+/+ and Sfrp3−/− virgin females at 6, 8 and 10 weeks of
age. The area bracketed in each whole mount image is shown below at higher magnification. Grey horizontal line illustrates the distance from the lymph
node (dashed vertical line) to the longest duct. Scale bar: 0.5 cm. e Quantification of the ductal length relative to the lymph node (LN) (left) and
quantification of the number of branch nodes (right) in MGs from Sfrp3+/+ and Sfrp3−/− virgin females at 6 (n= 4), 8 (n= 9), and 10 weeks (n= 2
Sfrp3+/+; 4 Sfrp3−/−) of age. f Representative whole mount of MGs from Sfrp3+/+ and Sfrp3−/− virgin females at 8 weeks of age compared to Sfrp3+/+
pregnant females (P8.5) of the same age. Scale bar: 0.25 cm. For a–c, e, data represent mean ± SD (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns,
not significant). See also Supplementary Fig. 1. Source data are provided as a Source Data file
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10509-1
4 NATURE COMMUNICATIONS |         (2019) 10:2481 | https://doi.org/10.1038/s41467-019-10509-1 | www.nature.com/naturecommunications
(Supplementary Fig. 4c), precluding that the branching pheno-
type of Sfrp3−/− mice is due to an increase in hormone levels.
Indeed, in Sfrp3−/− males (complete absence of ovarian function)
did not show any induction of the mammary tree (Supplementary
Fig. 4d). In summary, these results indicate that stromal Sfrp3
modulated epithelial MG development only in a hormonally
stimulated environment.
Sfrp3 modulate of Wnt signalling in MG development. Taking
into account that Wnt signalling pathway has been traditionally
associated with MG development7, and Sfrps are regulators of
Wnt signalling11,12, we hypothesise that Sfrp3 might control
mammary development through modulating Wnt signalling.
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Fig. 2 Sfrp3 loss disrupts lumen formation and epithelial architecture of ducts. a Representative images of HE-stained mammary glands from Sfrp3+/+ and
Sfrp3−/− virgin females at 8 weeks of age. Scale bar: 100 µm. b Quantitative analysis of the luminal filling phenotype showing an increase in the number of
ducts with occluded lumen in Sfrp3−/− compared to Sfrp3+/+ females at 8 weeks of age. n= 2 Sfrp3+/+; 3 Sfrp3−/−. Data represent mean ± SD (*p <
0.05). c, d Immunofluorescence staining for Keratin 14 (K14) and E-cadherin (E-cadh) (c) and for Keratin8 (K8) and E-cadherin (d) on mammary sections
of 8 weeks old females. The magnification of each bracketed area is shown on right side. Scale bar: 50 µm. e Immunofluorescence staining for E-cadherin
and ZO1 on mammary sections of 8 weeks old females. c–e Images are representative of at least 10 MG sections analysed in 5 different experiments. Scale
bar: 50 µm. See also Supplementary Fig. 2. Source data are provided as a Source Data file
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To address the role of Sfrp3 we used the wing imaginal disc of
Drosophila, a well-studied model to investigate morphogens
during development. Drosophila represents a natural Sfrp3 null
background since no Sfrp homologue has been identified in its
genome. We observed that ectopic expression of Sfrp3 in the
posterior compartment of the Drosophila wing imaginal disc
(driven by HhGal4) does not interfere with the symmetrical
gradient of Wingless (Wg) at the dorsoventral boundary of the
wing imaginal disc, but reduced its peak of concentration
there (Fig. 5a, b). Sfrp3 expression also dramatically abolishes
the expression of Senseless, a canonical target of Wg, but not the
expression of Cut, a target of Notch signalling (Fig. 5c, d).
Consistently, the adult wings of Drosophila expressing
NubGal4>UAS-Sfrp3 show a lack of sensory organs at the wing
margins, which is a characteristic phenotype of the inhibition of
Wg pathway (Fig. 5c). These results suggest that Sfrp3 acts as an
inhibitor of Wg pathway in Drosophila wing-imaginal-disc. To
validate this hypothesis, we also characterised the effect of Sfrp3
on Distalless (dll), a Wg target that response to low Wg
concentrations. We observed that Sfrp3 expression does not
inhibit dll, but instead broadens the dll territory in the P
compartment (Fig. 5f). Thus, while the effect on Sen seems to
support the conclusion that Sfrp3 overexpression inhibits Wg, the
effect on dll suggests that Sfrp3 expression might induce
the transport and diffusion of Wg, reducing its concentration at





























































































































































































Fig. 3 Increased proliferation and premature differentiation in Sfrp3−/− MG. a Representative images of immunofluorescence staining for Ki67, E-cadherin,
ZO1 and DAPI (left and middle) and for Cleaved Caspase 3 (CC3) and E-cadherin (right) on 8 weeks old MGs. Scale bar: 50 µm. b Quantification of the
number of Ki67 and CC3 positive cells in mammary ducts of 8 weeks old Sfrp3+/+ (n= 3) and Sfrp3−/− (n= 2) females. Data represent mean ± SD (**p <
0.01). c Representative images of immunofluorescence staining for Ki67, E-cadherin, Keratin 8 on 8 weeks old mammary glands. Scale bar: 50 µm.
d Representative images of immunofluorescence staining for ER (red) and E-cadherin (green), on 8 weeks old mammary glands. Scale bar: 50 µm.
e Quantification of the number of ER positive cells in mammary ducts of 8 weeks old Sfrp3+/+ (n= 2) and Sfrp3−/− (n= 2) females. Data represent
mean ± SD (***p < 0.001). f Representative images of immunofluorescence staining for ß casein and E-cadherin on mammary section from 10 weeks old
Sfrp3+/+ and Sfrp3−/− virgin females and Sfrp3+/+ pregnant females (P8.5). Scale bar: 50 µm. g Relative mRNA level of ß casein (upper), WAP (middle)
and Lalba (bottom) in MGs of Sfrp3+/+ (n= 3) and Sfrp3−/− (n= 4) virgin females at 10 weeks of age. h Representative images of immunofluorescence
staining for NaPI (red), E-cadherin (green), ß casein (blue) on 8 weeks old MGs. c, h Images are representative of at least 5 MG sections analysed in three
different experiments. Data represent mean ± SD (**p < 0.01, ***p < 0.001, ****p < 0.0001). See also Supplementary Fig. 2. Source data are provided as a
Source Data file
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(a high-concentration Wg-target) but expand dll territory (a low-
concentration Wg-target). In order to prove this role of Sfpr3 in
the transport and diffusion of Wg, we used a membrane-bound
form of Wg (NRT-Wg), described before to allow persistent
expression of relevant target genes24. Importantly, the expression
of Sfrp3 in the posterior compartment did not affect Sens
(Fig. 5g), demonstrating that Sfrp3 is not a repressor or inhibitor
of Wg, but more likely a transporter of Wg that allow the
spreading of this morphogen.
Next, we investigated whether canonical Wnt signalling is
abnormally activated in Sfrp3−/− MGs. Next-generation sequen-
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substantial up-regulation of LEF1 and cMYC in Sfrp3−/−
epithelial cells (Supplementary Data 1). However, the expression
levels of most canonical target genes like βcatenin, axin2, and
cyclinD1 are unchanged in Sfrp3−/− adults (Supplementary Fig. 5,
Supplementary Data 1). By contrast, we observed a substantial
nuclear accumulation of βcatenin in pubertal Sfrp3−/− MGs
(Fig. 6a, b), when the levels of expression of Sfrp3 are close to the
maximum level (Fig. 1a). Together these results demonstrate that
Sfrp3 acts as a specific modulator of canonical Wnt pathway.
Previous studies have shown that Wnt family members are
differentially regulated in mouse MGs during puberty and
pregnancy6. Since Sfrp3−/− MGs mimics an early pregnancy
state, we investigated whether the loss of Sfrp3 associates with an
alteration of Wnt ligands. We defined the cellular compartments
that express these Wnt ligands by cell sorting and qPCR analyses.
We determined that Wnt2 is more abundant in the stroma, while
Wnt5a and Wnt7b are more expressed in the epithelial cells in
adult virgin MGs (Fig. 6c). In line with this, NGS analysis
detected shallow levels of Wnt2 and higher levels of Wnt5a and
Wnt7b in wild-type epithelial cells (Supplementary Data 1).
Furthermore, we found that Wnt2 protein accumulated at the
stromal–epithelial boundary in Sfrp3−/− (Fig. 6d), while de-
epithelialised cleared fat pads of adult animals presented reduced
levels of expression ofWnt2 (Fig. 6e), which is consistent with the
decrease we observed in pregnant mice for Wnt2 (Supplementary
Fig. 6). This data suggests that Sfrp3 function might be related to
control the accumulation of Wnt2 at the stromal–epithelial
boundary since the loss of stromal Sfrp3 leads to an accumulation
of Wnt2 in the boundary, which is consistent with the role found
for Sfrp3 in Drosophila before. Altogether, our results suggest that
stromal Sfrp3 mediates the crosstalk between stroma and
epithelium through the modulation of stromal Wnt2 ligand.
To obtain a more precise idea of the molecular mechanism of
Sfrp3, we studied the secretion of SFRP3 in vitro and its
interaction with Wnt ligands. We found that myc-tagged SFRP3
requires the NTR domain to be secreted (Fig. 6f). Next, we
analysed the interaction of SFRP3 with different Wnts present in
the MG6. SFRP3 binds strongly to Wnt2 that is expressed by the
stromal cells, and to a lesser extent with Wnt5a or Wnt7b
expressed by the epithelial cells (Fig. 6g). Furthermore, we
observed that the NRT domain of SFRP3 binds to all Wnts
analysed, but this interaction is particularly strong with Wnt2
(Fig. 6h). The specific interaction of the NRT domain of Sfrp with
Wnts/Wg was previously described for SFRP125,26, another
member of the family. These results, combined with our previous
data, suggest that SFRP3 interacts with Wnt2 to control the
concentration levels of Wnt2 in the boundary of the
stromal–epithelial mammary.
Loss of Sfrp3 associates with cancer. Sfrp3−/− phenotype might
resemble early stages of carcinogenesis27,28. However, we could
not detect any defined tumour lesion like focal hyperplasia, dis-
ruption of the myoepithelial layer or change in collagen content
in the Sfrp3−/− mice. Neither, did we observe any palpable
tumour mass, or macroscopic lesion in nulliparous Sfrp3−/−
females of 12/15 month of age. We also monitored Sfrp3−/−
females mated and allowed to undergo several rounds of preg-
nancy, lactation, and involution. Again, Sfrp3−/− mice did not
develop any mammary tumour lesion, indicating that aging and
parity are not sufficient risk factors for tumour development in
Sfrp3−/− mice. Although these results suggest that, in the
absence of genetic changes that could provide a sensitised back-
ground, Sfrp3 does not act as tumour suppressor, we performed
an NGS analysis of sorted mammary gland epithelial cells to
identify transcriptomic changes pointing to tumorigenic
susceptibility.
A total of 1408 differentially expressed genes (DEGs, q-value <
0.05) were identified, including 813 upregulated and 595 down-
regulated genes in Sfrp3−/− compared to wild-type mammary
epithelial cells (Supplementary Data 1). From the top 100 DEGs
(50 upregulated and 50 downregulated) (Supplementary Data 2,
Supplementary Data 3, Fig. 7a) we selected a group of 56 genes
with a log2 fold change >2 or <−2. To investigate their
association with BC outcomes, we interrogated two independent
breast tumour datasets deposited in the publicly available
Oncomine database29, and we found data for 36 genes.
Importantly, 15 upregulated genes in Sfrp3−/− epithelial cells
are differentially expressed in BC versus normal samples. We
observed that the expression of 8 genes (Slc1a2, Larp1b, Lef1,
Edn2, Slc6a12, Fgf21, C1qtnf5 and Flt3l) is appreciably elevated in
invasive BC compared to normal breast samples using the Cancer
Genome Atlas (TCGA) dataset (Fig. 7b). All eight genes are
highly expressed in invasive ductal and/or lobular BC, except for
Flt3l that is notably highly expressed only in invasive lobular BC,
compared to controls. Furthermore, seven genes (Ecel1, Nr4a2,
Plk3, Dpp10, Saa2, Csn2 and Nrxn3) are considerably highly
expressed in the stroma of invasive BC (Fig. 7c).
We found similar evidence when we performed a tissue-
specific analysis of NGS data. From the total 1408 DEGs, we
selected 102 DEGs (74 upregulated and 28 downregulated genes)
that have been already described in the literature as associated
with mammary gland for expression or functional data
(Supplementary data 4) and we classified them into 20 KEGG
pathways. Among the top four false discovery rate (FDR) ≤ 10%,
we found “Proteoglycans in cancer” “and “Pathways in cancer”
signalling pathways (Fig. 7d). These data show that loss of Sfrp3
results in an epithelial gene expression profile that reflects
oncogenic processes. Finally, when classified into the biological
process (BP), the clusters with the top three enrichment scores
include processes of regulation of cell proliferation, positive
regulation of protein metabolic process and mammary gland
alveolus development (Supplementary Table 1).
Fig. 4 Loss of stromal Sfrp3 affects branching, ductal structure and differentiation. a Whole mount of transplanted and contralateral (not transplanted) MG
of CD1 females analysed 5 weeks after the operation. Upper panel, left, Sfrp3−/− donor epithelium is transplanted in Sfrp3+/+ stroma; bottom panel, left,
Sfrp3+/+ donor epithelium is transplanted in Sfrp3−/− stroma. Images are representative of n= 7 transplants of Sfrp3−/− donor epithelium in Sfrp3+/+
stroma; 7 transplants of Sfrp3+/+ donor epithelium in Sfrp3−/− stroma. Scale bar: 0.5 cm. b HE-stained transplanted MGS of CD1 females. Scale bar:
50 µm. c Left, high magnification view of transplanted MGs. Scale bar: 0.3 cm. Right, quantification of the number of branch nodes in Sfrp3+/+ MGs
transplanted with Sfrp3−/− donor epithelium (n= 5) and in Sfrp3−/− MGs transplanted with Sfrp3+/+ donor epithelium (n= 4). Data represent mean ± SD
(**p < 0.01). d Images of immunofluorescence staining for ZO1 (red), E-cadherin(green) and K14 (blue) in Sfrp3+/+ MGs transplanted with Sfrp3−/− donor
epithelium (upper panel) and in Sfrp3−/− MGs transplanted with Sfrp3+/+ donor epithelium (bottom panel) (n= 7). Scale bar: 50 µm. e Images of
immunofluorescence staining for ß casein (red) and E-cadherin (green) in Sfrp3+/+ MGs transplanted with Sfrp3−/− donor epithelium (upper panel) and in
Sfrp3−/− MGs transplanted with Sfrp3+/+ donor epithelium (bottom panel) (n= 7). d, e Images are representative of at least 10 MG sections analysed.
Scale bar: 50 µm. For d and e the magnification of the bracketed area is shown on right side. See also Supplementary Figs. 3 and 4. Source data are
provided as a Source Data file
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To further test the potential of sfrp3 as tumour suppressor in
the presence of genetic changes that provide a sensitised
background, we performed a crossed Sfrp3−/− mice with the
MMTV-Neu (MMTV-Erbb2), which produced tumours classi-
fied as human luminal type carcinomas30. We observed the
formation of preneoplastic lesions in the sfrp3−/− MMTV-Neu
mammary gland samples which are phenotypically similar
to the MMTV-Neu premalignant lesions described before
(Fig. 7e)30. Furthermore, we identified that lack of Sfrp3 in
MMTV-Neu animals induces a significative reduction in the
time of appearance of mammary tumours (from an estimated
median of 405 days in Srrp3+/− animals to 344 days in Sfrp3−/−
mice; p= 0.0148) (Fig. 7f), suggesting a role for Sfrp3 as relevant
marker for BC susceptibility. The analysis of the Sfrp3−/−;
MMTV-Neu mammary gland tumours by confocal
microscopy showed that the tissues present the characteristic
features of the Sfrp3−/− mammary ducts with β-casein
accumulated in the lumen of ducts and hyperproliferative
luminal cells (Fig. 7g).
Collectively, these results support the alterations in MG
morphogenesis we observed in Sfrp3−/− virgin females, and
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Discussion
In this study, we have identified a role for Sfrp3 in regulating
mammary epithelial development during puberty. We found that
the absence of Sfrp3 leads to alterations of MG development, with
ducts showing accelerated ductal invasion throughout the fat pad
and precocious tertiary branching. Loss of Sfrp3 leads to luminal
cell defects, bringing to alterations of the ductal architecture and
integrity. Sfrp3−/− luminal epithelial cells show increased pro-
liferation, with no change in the apoptosis level, loss of polarity
features and arrangement into multiple layers protruding and
occluding the ductal lumen.
Furthermore, Sfrp3−/− luminal epithelial cells produce milk
proteins, consistently with the observed increased tertiary side
branching that is typical of pregnancy. Maturation of alveolar
precursor cells and differential induction of milk protein genes
are mainly controlled by prolactin signalling, which is mediated
by JAK2 and STAT5A/B31,32. Our bioinformatic analysis of NGS
data suggests prolactin signalling as a potential pathway acting in
Sfrp3−/− epithelial cells (Fig. 7d). Future work will be needed to
better characterise the role of Sfrp3 in the regulation of prolactin
signalling.
Mammary stroma regulates the development and differ-
entiation of epithelial cells, defining as well the side branching
pattern33,34. This is partially due to a stromal–epithelial com-
munication by secreted factors acting on either an autocrine or
paracrine manner. A hallmark of MG development is the bi-
directional activity of these factors, which complicates the
identification of the source and target cells. Here we observed
that Sfrp3 is expressed in both compartments, but with eight-
fold more expression in the stroma. Furthermore, we showed
that loss of stromal Sfrp3 is responsible for the ductal pheno-
type observed in Sfrp3−/− MG. It is tempting to speculate that
the signals from Sfrp3−/− stroma are instructive since they can
target transplanted wild-type epithelial cells and participate in
their differentiation into multi-layered cells abnormally pro-
liferating and producing milk proteins. Recent studies have
unravelled new molecules responsible for the stromal-epithelial
communication in mammary epithelial morphogenesis35,36.
We propose SFRP3 as a mediator of the mammary
stromal–epithelial crosstalk.
The Sfrp proteins are traditionally considered the largest family
of secreted Wnt inhibitors. Pioneering studies showed that SFRP3
binds Wnt1 and Wnt8, and inhibits canonical Wnt signalling in
Xenopus embryo and cultured cells12,37. However, we demon-
strated that SFRP3 acts as a transporter a diffusor of Wg in
Drosophila, not an inhibitor. We thus hypothesised that Sfrp3
controls MG development by modulating Wnt signalling at the
stromal–epithelial boundary (Fig. 8). Indeed, secreted SFRP3
binds to Wnt2 through its NRT domain, and we detected a
substantial increase in Wnt2 accumulation at this boundary and
the activation of the Wnt-βcatenin pathway in pubertal Sfrp3−/−
whole MGs. Wnt-2, Wnt-5a and Wnt-7b are strongly expressed
during ductal development, in the TEB microenvironment, and
they seem to be regulators of mammary branching38,39. Indeed,
the ectopic expression of Wnt2 results in a hypermorphic
branching phenotype40.
Furthermore, we found that Wnt2 is expressed by stromal
fibroblast in the MG, and previous studies showed that Wnt2
expression accumulates preferentially in the stromal–epithelial
boundary38. Thus, our current data suggest that SFRP3 might act
in the MG as an extracellular transporter of Wnt ligands
enhancing their diffusion across cellular compartments. Sfrp3 and
Crescent have been shown to promote the diffusion of Wnt8 and
Wnt11 in Xenopus embryo41. In line with this, in the presence of
SFRP3, Wg displays a more diffuse distribution at the dorso-
ventral boundary of the Drosophila wing imaginal disc. We
propose that SFRP3 binds to stromal Wnt2 in order to diffuse this
ligand function to epithelial cells. In the absence of SFRP3, Wnt2
would accumulate in the stroma, resulting in an altered com-
munication with the epithelium, and a defective mammary epi-
thelial morphogenesis (Fig. 8). Future studies will be required to
dissect the complex scenario of stromal–epithelial communica-
tions better.
Similarly to Sfrp3, loss of Sfrp1 also leads to excessive side
branching with clear lobuloalveolar development in the mouse
mammary gland42. It is to note that, although loss of either Sfrp1
or Sfrp3 results in a similar mammary phenotype, distinct
molecular routes are activated in their absence at signalling level
in order to prompt mammary modifications. For example, in
contrast to Sfrp3−/− mice, Wnt4 and its downstream effector
RANKL mRNA levels are increased in Sfrp1−/− mammary gland
in comparison to wild-type glands42. Additionally, Sfrp1 expres-
sion is found mostly in basal/myoepithelial cells that lack Sfrp3
expression43,44. Lastly, previous work demonstrated that Sfrp1
and Sfrp2 control retinal neurogenesis in a Wnt-independent
manner45. These results altogether suggest that Sfrp1 and Sfrp3,
participate in alternative signalling cascades during MG devel-
opment. It will be interesting to address the function of other
members of the Sfrp family in light of the recent evidence
pointing to a stromal expression of Sfrp2 and Sfrp4 in both
normal and tumour samples16,46–48.
How is MG development regulated downstream of Wnt sig-
nalling? Previous studies reported that mouse models with the
activated expression of β-catenin display a precocious
Fig. 5 Sfrp3 modulates Wnt signalling in the Drosophila wing imaginal disc. a Wingless (Wg) expression is altered in wing imaginal disc expressing Sfrp3-
myc (grey) in the posterior compartment under Hh-Gal4 driver compared to the anterior compartment, which serves as control. Scale bar: 50 µm.
b Fluorescence intensity profile of Wg (grey value; arbitrary units) along yellow lines in the anterior (ant) and posterior (post) compartment of the wing
imaginal disc. c In Hh-Gal4>UAS-GFP, UAS-Sfrp3-myc imaginal discs, the Wingless target Senseless (Sens) expression is inhibited only in the posterior
compartment (delimited by GFP expression) but not in the anterior compartment that serves as control. On the contrary, the Notch target Cut is normally
expressed in these imaginal discs along the anterior-posterior axis. Scale bar: 50 µm. d Fluorescence intensity profile of Sens and Cut (grey value; arbitrary
units) along yellow lines in the anterior (ant) and posterior (post) compartment of the wing imaginal disc. e Adult Nub-Gal4>UAS-Sfrp3-myc wings
expressing Sfrp3 in the entire wing pouch and hinge show a lack of sensory organs along the margins that correspond to the dorsoventral boundary in
imaginal discs. A high magnification of the bracketed area is shown. f In Hh-Gal4>UAS-GFP, UAS-Sfrp3-myc imaginal discs, the Wingless target Distalless
(dll) expression is expanded in the posterior compartment (delimited by GFP/Sfrp3 expression) but not in the anterior compartment that serves as control.
Scale bar: 50 µm. Fluorescence intensity profile of dll and GFP (grey value; arbitrary units) along the dorsal yellow lines of the wing imaginal disc. g In NRT-
wg; Hh-Gal4>UAS-GFP, UAS-Sfrp3-myc imaginal discs, the Wingless target Senseless (Sens) expression is normal in the posterior compartment
(delimited by GFP expression), similarly to the anterior compartment that serves as control. Scale bar: 50 µm. h Fluorescence intensity profile of NRT-wg
and Sens a (grey value; arbitrary units) along yellow lines in the anterior (ant) and posterior (post) compartment of the wing imaginal disc. WT, wild-type.
Scale bar: 200 µm. Images and fluorescent intensity profiles are representative of at least 5 images of wing imaginal discs analysed in 3 different
experiments. For a, c, f, and g white dashed line delimitates posterior and anterior compartment
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lobuloalveolar development49, similar to the Sfrp3−/− phenotype.
We, therefore, expected that in the absence of stromal Sfrp3
canonical Wnt signalling would be activated. Indeed, we observe
nuclear accumulation of β-catenin in Sfrp3−/− whole MGs at
early puberty, when the levels of Sfrp3 are higher in the wild
types. Besides, the NGS analysis reveals an increase in the
expression level of β-catenin target genes LEF1 and cMYC in
Sfrp3−/− mammary epithelial cells compared to control. These
data suggest an early Sfrp3-Wnt transcriptional response in a
specific epithelial cell population in the MG50.
The Wnt pathway has emerged as a key signalling cascade
participating in mammary organogenesis and oncogenesis7.
Our NGS data analysis shows that the gene expression profile of
Sfrp3−/− epithelial cells is associated with BC. Indeed, the
hyperproliferation and disruption of epithelial apical polarity
phenotype that we observed in Sfrp3−/− MG could be reasonably
considered as the first steps of a tumorigenic process. Despite this
evidence, Sfrp3−/− mice did not develop any evident mammary
tumour lesion or palpable mass. Also, we did not detect any






















































































































































































Epithelial Sfrp3 +/+ Stromal Sfrp3 +/+



































Sfrp3 +/+ Sfrp3 –/–































































































































































































Fig. 6 Sfrp3 modulates Wnt signalling in the mammary gland. a Representative images of immunofluorescence staining for β-catenin (red), Troma (green)
and nuclei (blue), on 5-weeks-old MG. Arrow denote localisation of β-catenin at cellular junctions in controls (Sfrp3+/+). Scale bar: 50 µm. b Quantification
of the number of β-catenin positive cells in mammary ducts of 5 weeks old Sfrp3+/+ (n= 2, 5 mice) and Sfrp3−/− (n= 2, 8 mice) females. Data represent
mean ± SD (****p < 0.0001). c Relative mRNA level ofWnt2 (left), Wnt5a andWnt7b (middle) and Wnt16 (right) in whole MG from Sfrp3+/+ and Sfrp3−/−
females at 10 weeks of age. n= 6. d Representative images of immunofluorescence staining for Wnt2 (red), K8 (green), on 5-weeks-old MG. Arrow
denote localisation of Wnt2 at stromal-epithelial boundary. Images are representative of 3 MG sections analysed in 3 different experiments. Scale bar: 20
µm. e Relative mRNA level ofWnt2 (left) andWnt5a (right) in de-epithelialised cleared fat pad from Sfrp3+/+ and Sfrp3−/− females at 8 weeks of age. n=
4. f Left, schemes of wild-type myc-tagged SFRP3 and truncated variants. Numbers indicate the aa position of each conserved domain according to
UniProtKB database. SP, signal peptide; CRD, cysteine-rich domain; NTR, netrin-like domain. Right, western blot detection of SFRP3-myc in cell lysates and
supernatants of MDCKII expressing different variants. The lack of SP domain abolishes protein expression. SFRP3-NRT variant is expressed and secreted,
while SFRP3 CDR is expressed but not secreted in the medium. g Immunoprecipitation of SFRP3-myc followed by immunoblot with anti-myc, anti-V5 and
anti-HA antibody in HEK293 cells transiently co-transfected with wild-type human SFRP3 construct and Wnt2-V5, Wnt5a-V5 and Wnt7b-HA constructs.
αcont, cell lysate incubated with negative antibody conjugated beads; αmyc, cell lysate incubated with anti-myc antibody conjugated beads. h Pull-down of
GST-tagged forms of SFRP3 followed by immunoblot with anti-V5 and anti-HA antibody in HEK293 cells transfected with empty, Wnt2-V5, Wnt5a-V5 and
Wnt7b-HA constructs. αcont, cell lysate incubated with negative antibody conjugated beads; αmyc, cell lysate incubated with anti-myc antibody
conjugated beads. For c, d, e, data represent mean ± SD (***p < 0.001, ****p < 0.0001, ns, not significant). f–h blots are representative of 3 different
experiments. Source data are provided as a Source Data file
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initiate a process of mammary tumour growth and invasion51.
We hypothesise that the development of BC requires other
genetic and epigenetic changes. Indeed, mutations in canonical
Wnt genes, leading to abnormal activation of Wnt signalling, are
not sufficient to generate tumours on mouse models, but they
require cooperating mutations in order to result in preneoplastic
lesions52. We identified that lack of SFRP3 in MMTV-Neu ani-
mals induces the precocious appearance of premalignant lesions
(Fig. 7), suggesting a role for Sfrp3 as a relevant marker for BC
susceptibility.
In summary, we have demonstrated that Sfrp3 is a regulator of
MG morphogenesis, being central to the communication between
stromal and epithelial cells. Stromal Sfrp3 constrains epithelial
invasion and branching during puberty and controls luminal cells
proliferation and differentiation state, likely through the fine-tuning
of stromal–epithelial Wnt signalling (Fig. 8). The generation of
mouse models with specific loss of Sfrp3 in different mammary cell
compartments will be of extreme value to gain insights on the
communication pathways driving MG development.
Methods
Mouse lines. Generation of Sfrp3−/− mice in Swiss/CD1 background14 were a
kind gift from Prof F.P. Luyten (KU Leuven, Belgium) and were maintained for our
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Fig. 7 Sfrp3−/− epithelial cells show a cancer-associated profile. a Clustered heatmap of the top 100 DEGs between FACS-sorted Sfrp3+/+ and Sfrp3−/−
epithelial cells. Red, increased expression; turquoise, reduced expression. The names of the samples are shown below the heatmap. Sfrp3−/− samples: 508,
507, 506, 505. Sfrp3+/+ samples: 502, 503, 517, 504. Two technical replicates for each sample library were sequenced (X1/X2). b Oncomine analysis of
the top 100 DEGs. List of genes interrogated in the Cancer Genome Atlas (TCGA) dataset and found to be uregulated (p≤ 0.005) in invasive breast
carcinoma compared to control sample. c Oncomine analysis of the top 100 DEGs. List of genes interrogated in the Finak dataset and found to be
uregulated (p≤ 0.005) in the stroma of invasive breast carcinoma compared to control sample. d KEGG pathway analysis of 102 DEGs. The top 4
pathways with a false discovery rate (FDR)≤ 10% are shown. e Representative images of HE-stained mammary glands from MMTV-Neu; Sfrp3−/−
virgin females presenting tumours (bottom panels). Upper panels show the contralateral mammary gland used as a control, that present filled ducts.
Scale bar: 50 µm. f Quantitative analysis of the fraction of tumour-free animals in a MMTV-Neu+/−; Sfrp3−/− genotype (red line) compared to controls
(MMTV-Neu+/−; Sfrp3+/−). p= 0.01487746. g Representative images of immunofluorescence staining for Ki67 (red), E-cadherin (green), nuclei (blue)
(left panels); and Ki67 (red), β-casein (green), nuclei (blue) (right panels), on MMTV-Neu+/−; Sfrp3−/− virgin females presenting tumours. White square
denote area magnified on bottom panels. Scale bar: 50 µm. Images in e, g are representative of at least 4 MG sections analysed in 4 different experiments.
See also Tables S1, S2, S3, S4. Source data are provided as a Source Data file
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were sacrificed at 3, 6, 8 and 10 weeks of age for mammary gland developmental
studies. At the end of puberty (8 weeks of age) the oestrus cycle was monitored
daily by vaginal smear twice per day (early morning and late afternoon). Only age-
matched wild-type and Sfrp3−/− females with matching oestrus cycle were used for
studies. For pregnancy stages, mice were mated and inspected for the presence of
vaginal plug the following morning. The day of the vaginal plug was counted as day
0.5 of pregnancy. The first day after delivery was considered as lactation day 1 (L1).
For weight recording, litters were normalised at 7 pups at birth, and weight was
measured at day 11 and day 21 (weaning). Male mice were sacrificed at 6 weeks and
6 months of age for mammary gland studies. For transplantation experiments we
used CD1 mice and immunocompromised mice. NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
stock # 005557 (NSG mice, Jackson Laboratories, Maine, USA) were bred and
housed in the CIB animal facility. For analysis of tumorigenesis the Sfrp3−/− mice
were crossed with FVB/N-Tg(MMTVneu)202Mul/J mice (MMTVneu+/+) mice
(Jackson Laboratories, Maine USA); the F1 (Sfrp3+/− MMTVneu+/−) were
backcrossed to Sfrp3−/− mice. Genotypic analyses allowed to identify the Sfrp3−/−
MMTVneu+/− and Sfrp3+/− MMTVneu+/− genotypes. Appearance of mammary
tumours in these animals was analyzed twice weekly, to determine the fraction of
tumour-free animals over time.
All mice were housed and bred in a specific pathogen-free (SPF) barrier facility
with a 12-h light cycle and chow and water ad libitum. All experiments were
approved by the CBMSO’s Institutional and Spanish Regional Committees on
Ethics of animal research and were in adherence to the NIH “Guide for the Care
and Use of Laboratory Animals”. Investigators were not blinded to genotype group
allocations.
Fly stocks. The Gal4 drivers for ectopic expression experiments using the Gal4/
UAS system were hh-Gal4 (FBti0017278) and nub-Gal4 (FBti0016825). The
expression of hh-Gal4 is restricted to the posterior compartment of all imaginal
discs and the expression of nub-Gal4 occurs in the entire wing pouch and hinge.
The UAS line UAS-GFP (FBti0012493), together with the Gal4 lines, were obtained
from Bloomington Stock Centre (Indiana University, Bloomington, USA).
Antibodies and reagents. Monoclonal anti-E-cadherin (#610181) antibody was
obtained from BD Transduction Laboratories. Polyclonal anti-Keratin 14 (#PRB-
155P) antibody was obtained from BioLegend. Monoclonal anti-Keratin 8
(TROMA-I), anti-ZO1 (R26.4C), anti-Wingless (4D4) and anti-Cut (2B10) anti-
bodies were obtained from Developmental Studies Hybridoma Bank. The rabbit
anti-NaPi-11b sera was a kind gift of Dr J. Biber (Universityof Zurich, Zurich,
Switzerland) and was used 1:400.
Polyclonal anti-ß casein (M-14, sc-17971) antibody, and anti-ERα (F10. Sc-
8002; MC-20, sc-542) was obtained from Santa Cruz Biotechnology. Polyclonal
anti-Cleaved Caspase 3 (#9661) antibody was obtained from Cell Signalling.
Monoclonal anti-CD326 (EpCAM)-PE (#130-102-967), anti-CD45-FITC (#130-
102-778) and anti-CD49f-APC (#130-100-147) antibodies were obtained from
Miltenyii Biotec. Monoclonal anti-Ki67 (clone SP6, #MA5-14520) antibody and
polyclonal anti-c-myc antibody for staining on Drosophila (#PA1-981) were
obtained from Thermo Fisher Scientific. Mouse monoclonal anti-myc tag (clone
4A6, cat#05-724) antibody for IP and western blot, and anti-active b-catenin (8E7)
was obtained from Merck-Millipore. Polyclonal anti-V5 tag (#GTX117997) was
purchased from GeneTex. Polyclonal anti-HA tag (#H6908) antibody was obtained
from Sigma. Alexa Fluor 488/555/647-conjugated antibodies were obtained from
Thermo Fisher. Matrigel Growth Factor reduced (#356230) was obtained from BD
Biosciences. Chambered coverglasses (#155383) were obtained from LabTek.
RNeasy Plus Mini kit (#74134) was from Qiagen. ThermoScript RT-PCR System
(#11146-024) was obtained from Invitrogen. High Capacity RNA-to-cDNA kit
(#4387406) was from Thermo Scientific. GoTaq qPCR Master Mix (#A6002) was
obtained from Promega.
Genotyping PCR. Mice were genotyped by PCR analysis on genomic DNA extracted
from tail tip. Two combinations of primers were used, one specific for the Sfrp3+/+
allele (primers Sfrp3+/+ allele forward and reverse) and the other specific for the
Sfrp3−/− allele (primers Sfrp3−/− allele forward and reverse). MMTVneu+/+ transgenic
mice were genotyped by PCR using the primers oIMR0386 TTTCCTGCAGCAGCC
TACGC and oIMR0387 CGGAACCCACATCAGGCC to amplify the transgene, using
as internal control the amplification with the primers oIMR8744 CAAATGTTGCTTG
TCTGGTG and oIMR8745 GTCAGTCGAGTGCACAGTTT, following the conditions
described by the provider (The Jackson Laboratory).
Whole mount analysis of mammary glands. Abdominal (no. #4) glands were
dissected from mice and spread on glass slides. After fixation in Carnoy’s fixative
(60% ethanol, 30% chloroform, and 10% glacial acetic acid) for either 2–4 h at
room temperature or overnight at 4 °C, they were hydrated and stained with
Carmine alum overnight at room temperature. Stained mammary glands were
dehydrated, cleared in xylene overnight and mounted with Permount mounting
medium. Images were taken with a Nikon D750 digital camera and processed with
ImageJ.
For each gland, the ductal length was measured as the distance between the
lymph node and the distal end of the longest duct. Branching was quantified by
manually counting the total number of branch nodes within three fields either
adjacent to the sides of the lymph node for mammary gland or randomly
distributed for transplanted mammary gland.
Histological staining and analysis. For morphological analysis, carmine-stained
mammary glands were cleared in xylene, embedded in paraffin, sectioned at 5 µm
and stained with hematoxylin and eosin according to standard procedures. Images
were collected on a Zeiss Axioskop2 plus microscope equipped with a colour
charge-coupled device camera. Ducts with filled lumen were manually counted in
5–7 images per mammary section and expressed as a percentage of the total
number of ducts per image.
For collagen staining, mammary glands were fixed with 4% PFA overnight,
embedded in paraffin, sectioned at 5 µm and stained with PicroSirius red. Images of
Sirius red-stained sections were taken with a Nikon Eclipse TE2000-U microscope
under bright and polarised light and processed by using Image J software. The













































Fig. 8Model diagram of how stromal Sfrp3 regulates MG epithelial morphogenesis. In wild-type mammary gland SFRP3(+/+) secreted by the stroma binds
to Wnt2, likely contributing to diffuse the high level of stromal Wnt2 expression at the boundary. The crosstalk between stroma and epithelium is correct,
allowing luminal cells to properly polarise and organise as a monolayer. Ducts branch appropriately during puberty. In the absence of Sfrp3(−/−) stromal
level ofWnt2 concentrates at the boundary. The stromal–epithelial communication is altered, resulting in altered arrangement of luminal cells, that are less
polarised, overproliferate and produce β casein. Total levels of Wnt2 expression is reduced. Overall ducts are longer and hyperbranched. BM, basement
membrane
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number of the different coloured collagen fibres was measured as previously
described53. Briefly, we subtracted the black-component image from each polarised
image in order to eliminate interstitial space and non-collagen elements that are
birefringent materials as collagen. Within the subtracted image we determined the
hue (colour) of each pixel by using the following hue definitions: red 1–9 and
130–255; orange 10–38; yellow 39–51; green 52–128; interstitial space 129–229.
The number of pixels within each hue range per image was calculated and
expressed as a percentage of the total number of collagen pixels. The proportion of
thick collagen fibres per image is given as the sum of red, orange and yellow pixels
while the proportion of thin collagen fibres is due to green pixels percentage.
Eleven fields per mammary gland were imaged.
For the quantification of collagen content the total number of collagen pixels
(corresponding to hue range 1–255) was expressed as a percentage of the total
number of pixels per image. Eleven images per mammary gland were analysed. The
level of anisotropy of collagen fibres was measured by using the FibrilTool Image-J
plug as previously described54. For each image a ROI (region of interest) was
selected including one single mammary duct and the surrounding area of collagen.
A score for anisotropy was assessed for each ROI: 0 for no order (purely isotropic
arrays) and 1 for perfectly ordered, i.e., parallel fibrils (purely anisotropic arrays).
Between six and eleven images per mammary gland were analysed.
Immunofluorescence on mammary gland sections. Carmine-stained mammary
glands, after whole-mount pictures had been taken, were cleared in xylene,
embedded in paraffin and sectioned at 5 µm. Sections were deparaffinised and
rehydrated through a graded series of ethanols. Antigen retrieval was performed by
boiling sections in 10 mM sodium citrate buffer (pH 6) for 15 min. The sections
were blocked in PBS+ 3% BSA and then incubated with the primary antibodies
anti-K14 (1:200), anti-K8 (1:2), anti-E-cadherin (1:400), anti-ZO1 (1:500), anti-
CC3 (1:500), anti-Ki67 (1:500), anti-ERα (1/200), anti-b-catenin (1/100), anti-NaPI
(1/250) diluted in PBS+ 3% BSA overnight at 4 °C. After 3 washes in PBS, the
secondary antibodies rabbit 555 (1:500), mouse 488 (1:500), rat 555/647 (1:500),
plus nuclei marker DAPI (1:500) were applied in PBS+ 3% BSA for 1 h at room
temperature. When anti-β casein (1:1000) and goat 555 (1:500) were used as pri-
mary and secondary antibody, respectively, blocking was done with PBS+ 5%
donkey serum while the primary and secondary antibody solutions were PBS+ 1%
donkey serum. Sections were mounted with Mowiol mounting medium and
imaged using a Zeiss Confocal LSM710 microscope. Ki67 positive cells were
manually counted in 4–5 images per mammary section and expressed as a per-
centage of the total number of cells per image.
Clearing of mammary fat pad. For RNA extraction from three-weeks-old cleared
fat pad, mice of that age were sacrificed and the entire right abdominal mammary
gland was excised. The region between the nipple and the lymph node, containing
the endogenous epithelium, was separated from the fat pad (cleared) by performing
a cut just after the lymph node. The tissue between the nipple and the lymph node
was spread on a glass slide, fixed and stained with Carmine alum in order to
confirm that the entire rudimentary tree was removed. The cleared fat pad was
collected in RNA later (Invitrogen) and either stored at −80 °C or immediately
processed for RNA extraction.
For RNA extraction from 8-weeks-old cleared fat pad, 3-weeks-old mice were
anaesthetised and the right abdominal mammary gland was exposed through a
small mid-sagittal cut in the skin of the lower abdomen and oblique cuts along the
right hind leg. The connection between the abdominal (no. #4) and the inguinal
(no. #5) gland was cauterised to prevent ingrowth from the 5th gland. The
endogenous epithelium was eliminated by removing the tissue between the nipple
and the lymph node. The removed tissue was stained with Carmine alum to check
for cleared margins. After clearing of the mammary fat pad, the incision sites were
closed and mice were sacrificed 5 weeks after surgery. The right cleared mammary
fat pad was processed for RNA extraction while the left abdominal gland (not
operated) was analysed by whole mount carmine alum staining to check for proper
epithelial ducts development.
Mammary epithelial transplantation. Transplantation of epithelial ducts was
performed according to the standard procedure previously developed55. Three
weeks old females were used as recipients and were anaesthetised. The region
between the nipple and the lymph was excised from the abdominal mammary
gland. Eight weeks old females were used as donors of epithelium. Small pieces of
the abdominal mammary glands (1 mm, close to the lymph node) were cut and
placed into DMEM/F12 media buffered with HEPES and NaHCO3, 10% foetal
bovine serum (FBS) for the time of the surgery. One piece of donor epithelium was
freshly transplanted into the centre of the cleared fat pad of the recipient female.
When CD1 mice were used as recipients, the transplantation was performed only
in one mammary gland (right) while the contralateral (left) was left intact and used
as control. When NSG mice were used as recipients, the fat pad of both abdominal
glands was cleared. Sfrp3+/+ and Sfrp3−/− donor epithelium were transplanted
into the right and left cleared fat pad, respectively, of the same recipient female.
The transplants were analysed 5 weeks afterwards.
Ovariectomy. Both ovaries were removed from anaesthetised 3-weeks-old females
by performing two separate lateral incisions in the lower back. Five weeks after
surgery, females were sacrificed and mammary glands were harvested for whole
mount carmine alum staining.
3D culture of mammary organoids and staining. We purified mammary orga-
noids from CD1 mice following the protocol previously optimised and described
for FVB mice56. Mammary glands pairs #3, #4 (without lymph node), and #5 were
harvested from virgin 8 weeks old females. They were minced and digested in
collagenase buffer (DMEM/F12 medium with 2 mg/ml collagenase, 2 mg/ml
trypsin, 5% FBS, 5 μg/ml insulin, and 50 μg/ml of gentamicin) for 30–40 min at
37 °C. Samples were centrifuged at 1500 rpm for 10 min. To recover additional
epithelial tissue, the top fatty layer was resuspended in DMEM/F12 and centrifuged
again. The epithelial pellets were resuspended in DMEM/F12 and treated with 40 μl
DNase I (2 U/μl) for 3 min. They were then resuspended in DMEM/F12 and
centrifuged at 1500 rpm for 10 min in order to obtain a compact red pellet. After
four rounds of differential centrifugation (quick spin at 1500 rpm) the final white
pellet consisted mostly of organoids. Organoids were embedded in Matrigel
Growth Factor Reduced at 2 organoids/μl and plated as 75/μl suspensions in 4-well
Chambered coverglass over a 37 °C heating block. Gels were allowed to polymerize
for 50 min at 37 °C, 5% CO2, and then overlaid with organoid medium (DMEM/
F12 with 1% penicillin-streptomycin and 1% ITS). The medium was changed after
2 days and organoids were analysed after 6 days of culture. They were fixed with
2% PFA (15 min light shaking) and permeabilized with DPBS+ 0.5% TritonX-100
for 1 h at room temperature. After blocking with DPBS+ 10% FBS+ 1% BSA for
2 h at room temperature, organoids were incubated overnight at 4 °C with antibody
solution (DPBS+ 1% FBS+ 1% BSA) plus the primary antibody anti-K14 (1:2000).
Organoids were washed with DPBS+ 10% FBS (3×, 10 min each) and incubated
for 1 h with antibody solution plus the secondary antibody rabbit 488 (1:500),
phalloidin-555 (1:500), and DAPI (1:500). After three washes with DPBS, the
chamber was removed by cutting it with a razor blade and the glass bottom
coverslip was overlaid with PBS for imaging. A W-Plan Apochromat 40×/1.0W
objective lens (Carl Zeiss) in a laser scanning confocal microscope (Zeiss LSM 710)
was used for high magnification image acquisition.
Organoid size was quantified by measuring the longest axis of the organoid
while lumen size was quantified by measuring the longest axis of the central cavity.
Six to eighteen organoids were analysed per female.
Isolation of primary mammary cells by FACS. Mammary glands pairs #2, #3, #4,
and #5 were isolated from virgin 12-weeks-old females. They were chopped and
incubated in the dissociation solution (DMEM/F12 medium with 10× gentle col-
lagenase/hyaluronidase, 5% FBS and 50 μg/ml of gentamicin) overnight at 37 °C,
5% CO2. After dissociation, cells were washed in HBSS+ 2%FBS and centrifuged at
400 × g for 5 min. The pellet was incubated in HBSS+ 2%FBS+NH4Cl (mixture
1:4) for 10 minutes for lysis of red blood cells and centrifuged at 400×g for 5 min.
The resultant pellet contains epithelial cell organoids as well as stromal cells and
lymphocytes. To obtain a single-cell suspension, the pellet was gently pipetted for 3
min in 2 ml of trypsin-EDTA 0.25%, centrifuged, and then pipetted for 3 min in 2
ml Dispase II (5 mg/ml) and 200 μl DNaseI (1 mg/ml). After resuspension in
HBSS+ 2% FBS, cells were passed through a 40 µm cell strainer filter in order to
dissociate cell clumps and centrifuged. The pellet was blocked in FACS buffer (PBS
pH7+ 1 mM EDTA+ 25 mM HEPES)+ 10% FBS for 10 minutes and then
incubated for 10 minutes with the fluorescently labelled primary antibodies anti-
CD45, anti-CD326 (EpCAM), and anti-CD49f. Cells were washed from unbound
antibodies and immediately sorted on a BD FACS Aria Fusion Becton Dickinson
California flow cytometer (nozzle size 85 µm, sheet pressure 45 psi) equipped with
DIVA software. Cell viability was determined by using DAPI. Cell clusters and
doublets were electronically gated out.
Constructs generation. Human wild-type SFRP3 was expressed from pcDNA 3.1
myc-His (−) cloning vector (Invitrogen, Carlsbad, CA) (primers hSfrp3 used for
cloning). Truncated variants of myc-tagged Sfrp3 were obtained by PCR on human
wild-type Sfrp3 insert. The following primers were used: Sfrp3 ΔSP for generating
SFRP3 variant lacking the signal peptide sequence (SFRP3 ΔSP); Sfrp3 ΔCRD
(#1+ #2) for generating SFRP3 variant lacking the CRD domain (SFRP3 ΔCRD);
Sfrp3 ΔNTR for generating SFRP3 variant lacking the NTR domain (SFRP3
ΔNTR). Active Wnt2-V5 (Addgene plasmid #43809), Wnt4-V5 (Addgene plasmid
#43812) and Wnt5a-V5 (Addgene plasmid #43813) plasmids were a gift from Xi
He. Wnt7b-HA construct was kindly provided by Paola Bovolenta’s lab. For
injection in Drosophila, mouse Sfrp3 cDNA was fused in frame to a C-terminal myc
tag, cloned into a pUAST vector57 and then inserted in the attP site 3R (86Fb) to
generate a transgenic fly line expressing SFRP3 under the UAS promoter. UAS-
Sfrp3 was expressed using hh-Gal4 or nub-Gal4 drivers.
SFRP3 expressing stable clones and western blot. MDCKII cells were grown in
MEM+ 5% FBS. MDCK cells stably expressing either wild-type or truncated
SFRP3 variants were selected for 10 days using G418 (0.5 mg/ml). Stable clones
were grown in M12 wells plate until reaching confluency and then cultured in
serum-free MEM for 12 h. After that, supernatants were collected and cells were
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lysed in 200 μl of Laemmli 2× sample buffer. Supernatants were centrifuged at
2000 rpm for 5 min to remove cell debris. The pellet was discarded and 4 volumes
of cold 100% acetone were added to the supernatant. Samples were incubated
at −80 °C for 10 min and centrifuged at 15,000 rpm for 15 min at 4 °C. The
supernatant was discarded and the pellet was dried for 15 min at room tempera-
ture. Proteins were then resuspended in 400μl of Laemmli 2× sample buffer (Sigma
Aldrich). A total of 15 μl of cell lysate and 40 μl of medium were loaded on 10%
SDS-PAGE. Transblotted nitrocellulose membranes were incubated with anti-myc
antibody (1:500).
Immunoprecipitation. HEK293 cells were grown in MEM+ 5%FBS. The day
before transfection 2–2.2 × 106 cells were seeded in a P100 plate. Medium was
changed 1–3 h before transfection by Calcium Phosphate performed as following.
6.25 μg of the construct expressing the wild-type variant of human myc-tagged
SFRP3 and 18.75 μg of the construct expressing active V5/HA-tagged Wnt ligand
were mixed in water plus 61 μl of 2 M CaCl2. The DNA mix was added to 500 μl of
2× HBS pH7, incubated for 30–60 s, and added dropwise to cells. The following day
cells were lysed in 1 ml lysis buffer (150 mM NaCl, 50 mM Tris pH 8, 1% NP40,
protease inhibitors). After clearing with unconjugated Sepharose beads, half of the
lysate was incubated with anti-myc conjugated beads, and the remaining half was
incubated with a negative control antibody conjugated beads for 2 h at 4 °C. After
three washes with lysis buffer and one wash with PBS, the pellet was resuspended
in 500 μl Laemmli 2× sample buffer, and boiled. Fifteen microliter were loaded on
10% SDS-PAGE and analysed by western blot using anti-myc antibody (1:1000) for
detection of SFRP3, anti-V5 antibody (1:1000) for detection of Wnt2 and Wnt5a,
and anti-HA antibody (1:500) for detection of Wnt7b.
RNA extraction and quantitative PCR analysis. Mouse tissues were mechanically
homogenised and total RNA was extracted by Trizol Reagent (Invitrogen)
according to the manufacturer’s protocols. FACS-sorted cells were immediately
lysed in Trizol Reagent and total RNA was purified by RNeasy Plus spin
column kit.
For RT-PCR on mouse tissues one μg RNA was reverse transcribed with the
ThermoScript RT-PCR system using random hexamers. Sfrp3 (primers pair #1)
and GAPDH (as normaliser gene, primers pair #1) were amplified from 2 µl of
CDNA. For quantitative Real Time PCR one μg RNA for tissue sample or 600 ng
RNA for FACS-sorted cells sample was retrotranscribed to cDNA with the High
Capacity RNA-to-cDNA kit. Real Time PCR was performed on 10 ng of CDNA
using the GoTaq qPCR Master Mix and 2.5 μM gene-specific primers in a final
volume of 10μl using the ABI 7900HT. The genes amplified from mouse tissue
were: Sfrp3 (primers pair #2), Wnt2, Wnt5a, Wnt7b, Wnt16, ß casein, Lalba, WAP,
axin2, cyclinD1. The genes amplified from sorted cells were Sfrp3 (primers pair #2),
Wnt2, Wnt5a, Wnt7b, CD24a, CD49f, Aldha1a. ßactin, GAPDH (primers pair #2)
and Ppia were used as internal controls. All primer sets were tested for primer
efficiency using a six-fold dilution series containing six dilutions. Conditions
of Real Time quantitative PCR were as follows: 95 °C for 10 min, then 40 cycles of
95 °C for 15 s and 60 °C for 1 min followed by a dissociation stage. The data were
analysed using comparative CT. All qPCR results were obtained from three
biological repeats and at least two technical repeats.
Low-input RNA sequencing. RNA sequencing libraries were prepared following
the SMARTseq2 protocol58 with some modifications. Briefly, RNA was quanti-
fied using the Qubit RNA HS Assay Kit (Thermo Fisher Scientific) and 10 ng of
RNA was used for cDNA synthesis. Reverse transcription was performed using
SuperScript II (Invitrogen) in the presence of oligo-dT30VN (1 µM), template-
switching oligonucleotides (1 µM) and betaine (1 M). The cDNA was amplified
using the KAPA Hifi Hotstart ReadyMix (Kappa Biosystems), 100 nM ISPCR
primer and 8 cycles of amplification. Following purification with Agencourt
Ampure XP beads (1:1 ratio; Beckmann Coulter), product size distribution and
quantity were assessed on a Bioanalyzer using a High Sensitivity DNA Kit
(Agilent). Two hundred nanogram of the amplified cDNA was fragmented for
10 min at 55 °C using Nextera® XT (Illumina) and amplified for 12 cycles with
indexed Nextera® PCR primers. Products were purified twice with Agencourt
Ampure XP beads (0.8:1 ratio) and quantified again on a Bioanalyzer using a
High Sensitivity DNA Kit.
The Nextera® libraries were sequenced on HiSeq2000 (Illumina, Inc) in paired-
end mode with a read length of 2 × 76 bp using TruSeq SBS Kit v4 and TruSeq Dual
Index of 8 bp+ 8 bp. We generated a mean of 42 million paired-end reads for each
sample in a fraction of a sequencing v4 flow cell lane, following the manufacturer’s
protocol. Image analysis, base calling and quality scoring of the run were processed
using the manufacturer’s software Real Time Analysis (RTA 1.18.66.3) and
followed by generation of FASTQ sequence files by CASAVA.
Bioinformatics analysis. More than 3 Gb of sequencing reads were obtained from
each sample in fastq format. Quality analyses were performed over reads using
FastQC software. Reads were to M. musculus reference genome (GRCm38) using
tophat2 v2.0.14 with default parameters.
Differential expression analysis was performed using Cuffdiff v2.2.2 package,
obtaining the expression values (RPKM) for each gene. A total of 1408 DEGs
(RPKM > 1, q value < 0.05) were identified. Two datasets (TCGA and Finak)
publicly available in Oncomine cancer microarray database were used to examine
the expression of the top 100 DEGs in BC tissues. We selected p ≤ 0.005 as a
threshold. Also, a Functional Enrichment Analysis (FEA) on a subgroup of 102
DEGs genes of interest was performed with an in-house R script that uses the
FGNet package.
Immunostaining on Drosophila wing imaginal discs. Imaginal discs were dis-
sected in PBS, fixed in 4% PFA for 20 min at room temperature. They were blocked
in PBS+ 1%BSA+ 0.3% TritonX-100 for 1 h at room temperature and then
incubated with primary antibodies in PBST-BSA overnight at 4 °C, washed four
times in blocking buffer and incubated with the appropriate fluorescent secondary
antibody for 1 h at room temperature in the dark. They were then washed and
mounted in Vectashield mounting medium. Primary antibodies used were: rabbit
anti-c-myc (1:500), mouse anti-Wingless 4D4 (1:50), mouse anti-Cut 2B10 (1:100)
and guinea pig anti-Sens (1:1000, a gift from Isabel Guerrero), and mouse anti
Distalless (dll) (1:1000, a gift from Carlos Estella59). Confocal images were captured
using an A1R+Nikon confocal microscope.
Quantification and statistical analysis. Results are expressed as the mean ±
standard deviation (SD). To calculate statistical significance, the two tailed Stu-
dent’s t-test was used. Sample size n is reported for each experiment in figure
legends. p value < 0.05 was considered significant. All calculations were performed
using Prism software.
Data availability
The authors declare that all data supporting the findings of this study are available within
the article and its supplementary information files or from the corresponding author
upon reasonable request. The uncropped and unprocessed scans of the most important
blots, and the excel tables of all quantifications can be found in the Source Data file in the
Supplementary Information.
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